Who is sponsoring NCT02369523?

NCT02369523 is sponsored by University of Utah.

What drugs are being tested in NCT02369523?

Interventions: Exparel, Ropivacaine cocktail (PIC), Bupivacaine.

What is the status of NCT02369523?

NCT02369523 is currently TERMINATED.

Last reviewed 2023-08-14 · How we verify

Periarticular Infusion With Liposomal Bupivacaine or a Ropivacaine Cocktail Versus Continuous Femoral Nerve Catheters for Multimodal Pain Management Following Primary TKA: A Randomized Controlled Trial

NCT02369523 EARLY_PHASE1 TERMINATED

The investigators plan to evaluate the length of time to discharge readiness between the groups (continuous femoral nerve blocks (cFNB) vs. liposomal bupivacaine (LB) vs. periarticular infusion cocktails (PIC) following primary total knee arthroplasty (TKA). In addition, the investigators will compare quadriceps strength recovery over time and exploratory variables between the groups.

Details

Lead sponsor	University of Utah
Phase	EARLY_PHASE1
Status	TERMINATED
Enrolment	84
Start date	2014-09
Completion	2017-04

Conditions

Pain

Interventions

Exparel
Ropivacaine cocktail (PIC)
Bupivacaine

Primary outcomes

Time to Discharge Readiness — Participants will be followed for the duration of hospital stay, an average of 3 days
Time to discharge readiness will be defined as the time from surgical stop to the time of the 2nd consecutive assessment where all criteria are fulfilled.

Countries

United States